Help us protect people with type 2 diabetes from heart attacks, strokes and other health problems
Over 400 million people live with diabetes around the world
1 in 10 people will have diabetes by 2035
People with diabetes are more likely to develop heart and circulatory problems
ASCEND PLUS is a UK-wide clinical trial testing a tablet medication called oral semaglutide, which might help to protect against heart attacks, strokes and circulatory problems in people with type 2 diabetes.
The study, run by the University of Oxford, will include 20,000 people with type 2 diabetes.